부인암 환자의 말초신경병증과 삶의 질
정주현, 노주희, 김기숙 et al. · 2013
Purpose: The purpose of this study was to identify chemotherapy induced peripheral neuropathy, quality of life of patients with gynecologic cancer. Methods: This was a cross-sectional survey design. We collected 130 patients with gynecologic cancer. They complete a self reported questionnaire including items related neuropathy and quality of life (FACT-GOG/Ntx subscale, FACT-G scale). Results: The neuropathy score was 14.3±7.9. The quality of life score was 64.8±16.4. The neuropathy induced significant difference according to diabetic status, difficulties in performing household chores and willing to discontinuity of chemotherapy. And duration of cancer diagnosis, neuropathy,number of total chemo agent associated with quality of life. There was a negative correlation between number of total chemo agent and quality of life. Neuropathy independently affected quality of life. Conclusion: Chemotherapy induced peripheral neuropathy of patients with gynecologic cancer adversely affected women`s quality of life and activities of daily living. To improve patient`s quality of life, it is important that accurate assess and appropriately manage neuropathy in patients with gynecologic cancer
Cited by 0 works.
Authors
References
- Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
- Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy
- Cancer pain and its impact on diagnosis, survival and quality of life
- Understanding Peripheral Neuropathy in Patients With Cancer: Background and Patient Assessment
- Quality improvement of painful peripheral neuropathy
- Characteristics and Quality of Life in Patients with Chemotherapy-Induced Peripheral Neuropathy
- Peripheral Neuropathy in Patients With Gynecologic Cancer Receiving Chemotherapy: Patient Reports and Provider Assessments